HealthcareServices

Global Stem Cell Umbilical Cord Blood Market 2026–2030: Forecast Insights for Business Planning

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the stem cell umbilical cord blood market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Stem Cell Umbilical Cord Blood Market?

The stem cell umbilical cord blood market size has seen significant growth in recent years. This market is projected to expand from $7.98 billion in 2025 to $9.39 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.7%. Historically, this expansion has been driven by an elevated use of stem cell transplants, the proliferation of public cord blood banks, advancements in hematological treatments, increased public awareness of stem cell therapies, and enhancements in neonatal healthcare infrastructure.

The stem cell umbilical cord blood market is expected to experience significant growth in the coming years. It is projected to expand to $17.83 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.4%. This anticipated growth during the forecast period is attributable to an increasing demand for personalized regenerative therapies, rising investments in cell therapy research, the expansion of treatments for neurological and immune disorders, the growing adoption of hybrid banking models, and advancements in stem cell expansion technologies. Major trends observed in the forecast period include the increasing adoption of advanced cryopreservation technologies, the rising utilization of stem cells in regenerative medicine, the growing expansion of private cord blood banking services, an enhanced focus on cell quality and viability preservation, and the expansion of hybrid cord blood storage models.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24715&type=smp

Which Drivers Are Supporting The Rise Of The Stem Cell Umbilical Cord Blood Market?

Increasing childbirth rates are anticipated to fuel the expansion of the stem cell umbilical cord blood market. Childbirth rates are defined as the count of live births per 1,000 individuals within a population over a designated timeframe, typically a year. The rise in these rates can be attributed to enhanced accessibility and reduced costs of fertility treatments, empowering more families to have children. Umbilical cord blood stem cells hold significant value for infants because they possess hematopoietic stem cells, which are effective in treating diverse blood, immune, and genetic conditions. These cells offer an exact genetic match for the infant and can also be beneficial for siblings or other family members. For instance, in April 2025, the U.S. Centers for Disease Control and Prevention, a U.S.-based federal agency, reported that the number of births in the USA rose from 3,596,017 in 2023 to 3,622,673 in 2024, indicating a 1% increase. Consequently, the rising childbirth rates are a key factor propelling the growth of the stem cell umbilical cord blood market.

What Segments Are Identified Within The Structure Of The Stem Cell Umbilical Cord Blood Market?

The stem cell umbilical cord blood market covered in this report is segmented –

1) By Product Type: Cord Blood Stem Cells, Cord Tissue Stem Cells

2) By Technology: Cryopreservation, Stem Cell Expansion, Cell Separation

3) By Storage Services: Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks

4) By Application: Hematological Disorders, Metabolic Diseases, Immune System Disorders, Neurological Disorders, Other Applications

5) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users

Subsegments:

1) By Cord Blood Stem Cells: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Endothelial Progenitor Cells, Regulatory T Cells, Natural Killer Cells, Dendritic Cells

2) By Cord Tissue Stem Cells: Mesenchymal Stem Cells, Epithelial Cells, Fibroblasts, Neural Progenitor Cells

Which Competitive Trends Are Impacting The Structure Of The Stem Cell Umbilical Cord Blood Market?

Leading companies in the stem cell umbilical cord blood market are concentrating on developing innovative treatments and securing approvals, such as cord blood cell therapy, to address rare genetic disorders, enhance immune system recovery, and support regenerative medicine applications. Cord blood cell therapy involves using stem cells derived from umbilical cord blood to treat various diseases by repairing or regenerating damaged blood, immune, and other tissue systems. For instance, in October 2024, StemCyte, a US-based biotechnology company, received the regenerative medicine advanced therapy designation from the U.S. Food and Drug Administration (FDA) for hematopoietic progenitor cell cord blood therapy (HPC Cord Blood) for the treatment of Long COVID-19 syndrome. This specific cord blood cell therapy utilizes stem cells from umbilical cord blood to encourage healing and diminish inflammation. It has demonstrated potential in treating immune-related and degenerative conditions, providing a non-invasive, ethically sourced option for advanced regenerative treatments.

Which Key Players Are Driving Competition In The Stem Cell Umbilical Cord Blood Market?

Major companies operating in the stem cell umbilical cord blood market are Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, StemLife Berhad, MediPost Co Ltd, Smart Cells International Ltd, StemCyte Inc, Celularity Inc, Next Biosciences Pty Ltd, Esperite NV, Cryo Cell International Inc, FamiCord Group, Cells4Life Group LLP, Cryoviva Biotech Pvt Ltd, Americord Registry LLC, ViaCord LLC, China Cord Blood Corporation, CBR Systems Inc, Cord Blood Registry, LifeCell International Pvt Ltd, CryoSave India Pvt Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/stem-cell-umbilical-cord-blood-global-market-report

Which Region Is Projected To Lead The Stem Cell Umbilical Cord Blood Market During The Forecast Period?

North America was the largest region in the stem cell umbilical cord blood market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell umbilical cord blood market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Stem Cell Umbilical Cord Blood Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24715&type=smp

Browse Through More Reports Similar to the Global Stem Cell Umbilical Cord Blood Market 2026, By The Business Research Company

Stem Cell Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Stem Cell Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Stem Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795